9-cis beta-carotene-enriched diet significantly improved cognition and decreased Alzheimer's disease neuropathology and neuroinflammation in Alzheimer's disease-like mouse models

Neurobiol Aging. 2024 Jan:133:16-27. doi: 10.1016/j.neurobiolaging.2023.09.005. Epub 2023 Sep 20.

Abstract

A significant progressive decline in beta-carotene (βC) levels in the brain is associated with cognitive impairment and a higher prevalence of Alzheimer's disease (AD). In this study, we investigated whether the administration of 9-cis beta-carotene (9CBC)-rich powder of the alga Dunaliella bardawil, the best-known source of βC in nature, inhibits the development of AD-like neuropathology and cognitive deficits. We demonstrated that in 3 AD mouse models, Tg2576, 5xFAD, and apoE4, 9CBC treatment improved long- and short-term memory, decreased neuroinflammation, and reduced the prevalence of β-amyloid plaques and tau hyperphosphorylation. These findings suggest that 9CBC has the potential to be an effective preventive and symptomatic AD therapy.

Keywords: 9-cis beta-carotene; Alzheimer’s disease; Beta-carotene; Cognition; Dunaliella; Inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Animals
  • Cognition
  • Diet
  • Disease Models, Animal
  • Mice
  • Neuroinflammatory Diseases*
  • Plaque, Amyloid
  • beta Carotene / pharmacology
  • beta Carotene / therapeutic use

Substances

  • beta Carotene